ES2491619T3 - Uso de bacterias coliformes productoras de gas inhibidoras de lactobacilos aisladas a partir de lactantes afectados por cólicos - Google Patents

Uso de bacterias coliformes productoras de gas inhibidoras de lactobacilos aisladas a partir de lactantes afectados por cólicos Download PDF

Info

Publication number
ES2491619T3
ES2491619T3 ES10743216.3T ES10743216T ES2491619T3 ES 2491619 T3 ES2491619 T3 ES 2491619T3 ES 10743216 T ES10743216 T ES 10743216T ES 2491619 T3 ES2491619 T3 ES 2491619T3
Authority
ES
Spain
Prior art keywords
colic
lactobacillus
coli
coliform bacteria
bacteria isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10743216.3T
Other languages
English (en)
Inventor
Gianna Scatizzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Probiotical SpA
Original Assignee
Probiotical SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical SpA filed Critical Probiotical SpA
Application granted granted Critical
Publication of ES2491619T3 publication Critical patent/ES2491619T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una cepa de bacterias probióticas seleccionada del grupo que comprende cepas de bacterias pertenecientes a la especie Lactobacillus delbrueckii, en la que dicha cepa probiótica es Lactobacillus delbrueckii MB386, depositada en la DSMZ el 10.12.2008 y con número de expediente DSM 22106, como inhibidor de bacterias coliformes.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
E10743216
11-08-2014
Tabla n.º 2
Sujetos n.º
Coliformes totales (UFC g-1 heces)* N.º de colonias morfológicamente diferentes en la placa Factor de dilución en la placa Especie identificada
2
5,0 x 106 2 a. 10-6 b. 10-6* a. E. coli b. E. coli
3
1,0 x 106 2 a. 10-6 b. 10-4 a. K. pneumoniae b. E. coli
4
1,0 x 107 2 a. 10-6 a. E. coli b. K. oxytoca
7
2,0 x 107 1 a. 10-7 a. E. faecalis
9
7,0 x 103 1 a. 10-3 a. E. coli
12
4,0 x 107 2 a. 10-7 b. 10-7 a. E. coli b. K. pneumoniae
13
3,7 x 107 2 a. 10-7 b. 10-7 a. E. coli b. E. coli
15
3,4 x 108 2 a. 10-8 b. 10-5 a. E. coli b. E. coli
16
4,3 x 108 2 a. 10-8 b. 10-5 a. E. coli b. K. oxytoca
17
1,1 x 106 2 a. 10-6 b. 10-5 a. E. coli b. Enterobacter cloacae
18
8,1 x 106 2 a. 10-6 b. 10-5 a. K. oxytoca b. E. faecalis
22
1,1 x 103 1 a. 10-3 a. E. coli
23
9,5 x 106 4 a. 10-6 b. 10-6 c. 10-6 d. 10-5 a. K. oxytoca b. E. aerogenes a. E. coli b. E. coli
24
1,0 x 103 1 a. 10-3 a. E. coli
29
5,8 x 108 2 a. 10-8 b. 10-7 a. E. coli b. E. coli
32
2,7 x 106 4 a. 10-6 b. 10-5 c. 10-5 d. 10-5 a. E. coli b. K. oxytoca c. K. pneumoniae d. K. oxytoca
36
1,0 x 104 1 a. 10-4 a. K. oxytoca
39
1,0 x 104 1 a. 10-4 a. K. pneumoniae
48
2,6 x 106 1 a. 10-6 a. K. oxytoca
(*) el número total de coliformes se determinó contando las colonias que habían proliferado sobre placas de agar de MacConkey, mientras que las concentraciones de las especies se determinaron usando el procedimiento de huella genética por PCR específico de especie y por ribotipado.
11

Claims (1)

  1. imagen1
    imagen2
ES10743216.3T 2010-06-28 2010-06-28 Uso de bacterias coliformes productoras de gas inhibidoras de lactobacilos aisladas a partir de lactantes afectados por cólicos Active ES2491619T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2010/001554 WO2012001440A1 (en) 2010-06-28 2010-06-28 Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic

Publications (1)

Publication Number Publication Date
ES2491619T3 true ES2491619T3 (es) 2014-09-08

Family

ID=42989661

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10743216.3T Active ES2491619T3 (es) 2010-06-28 2010-06-28 Uso de bacterias coliformes productoras de gas inhibidoras de lactobacilos aisladas a partir de lactantes afectados por cólicos

Country Status (11)

Country Link
US (1) US9255246B2 (es)
EP (1) EP2585085B1 (es)
JP (1) JP2013531506A (es)
CN (1) CN103079580B (es)
BR (1) BR112012033212B1 (es)
DK (1) DK2585085T3 (es)
ES (1) ES2491619T3 (es)
PL (1) PL2585085T3 (es)
RU (1) RU2544054C2 (es)
UA (1) UA107711C2 (es)
WO (1) WO2012001440A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110679A1 (it) * 2011-04-20 2012-10-21 Giovanni Mogna Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITRM20110475A1 (it) * 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
CN106459876A (zh) * 2014-03-28 2017-02-22 促接合因子股份有限公司 治疗性细菌的小菌落变异株的制备
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
CN107924409B (zh) * 2015-08-12 2022-04-08 爱康迪健康规划服务股份有限公司 信息处理装置、信息处理方法和记录介质
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
AU2017217350A1 (en) * 2016-02-12 2018-08-09 Hulka S.R.L. Use of bacterial strains belonging to the species Lactobacillus kefiri in paediatrics to generate and/or maintain a state of homeostasis
ITUB20160708A1 (it) * 2016-02-12 2017-08-12 Probiotical Spa Uso di ceppi di batteri appartenenti alla specie Lactobacillus kefiri in pediatria per generare e/o mantenere lo stato di omeostasi.
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
KR102135195B1 (ko) * 2018-10-08 2020-07-17 아주대학교산학협력단 테트라제노코커스 할로필러스를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물
CN113142396A (zh) * 2021-06-11 2021-07-23 中国农业大学 一种制备豆科牧草青贮饲料用菌剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040161422A1 (en) 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
CA2549115C (en) * 2002-09-26 2013-07-16 Vita-Herb Nutriceuticals, Inc. Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
JP4387972B2 (ja) * 2005-04-14 2009-12-24 大洋香料株式会社 抗酸化剤
RU2391393C1 (ru) 2008-11-19 2010-06-10 Галина Геннадиевна Алехина ШТАММ Lactobacillus delbrueckii TS1-06, ИСПОЛЬЗУЕМЫЙ ДЛЯ ИЗГОТОВЛЕНИЯ БАКТЕРИАЛЬНЫХ ПРЕПАРАТОВ И ПРОИЗВОДСТВА ЖИДКОЙ МОЛОЧНОКИСЛОЙ ЗАКВАСКИ В КАЧЕСТВЕ ПРОДУКТА ПИТАНИЯ ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОГО НАЗНАЧЕНИЯ

Also Published As

Publication number Publication date
EP2585085B1 (en) 2014-05-28
CN103079580B (zh) 2015-04-29
DK2585085T3 (da) 2014-06-23
PL2585085T3 (pl) 2014-10-31
US9255246B2 (en) 2016-02-09
RU2544054C2 (ru) 2015-03-10
BR112012033212A2 (pt) 2016-10-25
CN103079580A (zh) 2013-05-01
WO2012001440A1 (en) 2012-01-05
EP2585085A1 (en) 2013-05-01
RU2013102424A (ru) 2014-08-10
JP2013531506A (ja) 2013-08-08
US20130195823A1 (en) 2013-08-01
BR112012033212B1 (pt) 2021-06-08
UA107711C2 (en) 2015-02-10

Similar Documents

Publication Publication Date Title
ES2491619T3 (es) Uso de bacterias coliformes productoras de gas inhibidoras de lactobacilos aisladas a partir de lactantes afectados por cólicos
ES2561253T3 (es) Bacterias probióticas que tienen actividad antioxidante y uso de las mismas
ES2524432T3 (es) Bacterias del ácido láctico como cepas probióticas y composiciones que contienen las mismas
MY151204A (en) Lactobacillus plantarum and uses thereof
ES2550059T3 (es) Método para usar una cepa de Bacillus subtilis para la profilaxis y el tratamiento de afecciones gastrointestinales
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
CL2011001939A1 (es) Uso de lactobacillus helveticus cncm i-4095 para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales, particularmente para tratar la obesidad y trastornos metabólicos; y microorganismo de la cepa de lactobacillus helveticus cncm i-4095.
CL2017003193A1 (es) Composiciones que comprenden cepas bacterianas
CL2011001937A1 (es) Uso de la cepa de lactobacillus rhamnosus cncm i-4096 para apoyar la pérdida de peso y/o mantenimiento del peso en humanos y/o animales, específicamente para el tratamiento de la obesidad.
MX2020005875A (es) Métodos y composiciones para prevenir la infección microbiana.
PH12015502416A1 (en) Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
AR093061A1 (es) Metodos y composiciones para el tratamiento y control de enfermedades en las plantas
MX2022003927A (es) Cepas y procesos para la produccion de biomasa o proteina de celulas individuales.
AR069087A1 (es) Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
CL2022001042A1 (es) Bacterias productoras de serotonina
AR075013A1 (es) Composicion farmaceutica para proteger a un animal contra un trastorno causado por una infeccion con una bacteria que pertenece al grupo de acttinomicetes nocardioformes. uso. metodo.
ES2482666B1 (es) Uso de la cepa CECT 7426 para provocar quorum quenching de la señal autoinductor-2 (AI-2)
ES2564455T3 (es) Método de autenticación de productos lácteos
PL386175A1 (pl) Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Enterococcus
Lunestad et al. Microbiota of lutefisk, a Nordic traditional cod dish with a high pH
MX2016003676A (es) Bacteria aislada del genero streptomyces.
Ahn et al. Influence of bacteriophage P22 on the inflammatory mediator gene expression in chicken macrophage HD11 cells infected with Salmonella Typhimurium
CN102994456A (zh) 一种人工合成的s13噬菌体及其应用
Nanthakumar et al. IN VITRO ANTIMICROBIAL ACTIVITY OF AQUEOUS AND ETHANOL EXTRACTS OF RHINACANTHUS NASUTUS-A MEDICINAL PLANT.
DE602005012807D1 (de) Antibiotikasensitive Milchsäurebakterienstämme